In addition, VEGF-C and VEGFR-3, which together have been proposed as a marker for lymphatic endothelial cells, have recently been reported to be expressed by tumor cells in correlation with the invasion, metastasis and progression of cancer cells (6–8). The gene discussed is FLT4; the disease is neoplasm.